BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31865196)

  • 1. Haematological side effects associated with clozapine: A retrospective study from India.
    Grover S; Shouan A; Chakrabarti S; Avasthi A
    Asian J Psychiatr; 2020 Feb; 48():101906. PubMed ID: 31865196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine-induced blood dyscrasias in Saudi Arab patients.
    Abanmy NO; Al-Jaloud A; Al-Jabr A; Al-Ruwaisan R; Al-Saeed W; Fatani S
    Int J Clin Pharm; 2014 Aug; 36(4):815-20. PubMed ID: 24917217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine-Induced Eosinophilia: a Case Report.
    Monteleone F; Gonçalves M; Fonseca L; Simões S; Gonçalves A; Machado E; Fonseca J
    Rev Colomb Psiquiatr (Engl Ed); 2023; 52(2):161-164. PubMed ID: 37500239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine-associated severe eosinophilia following lithium rebound neutropenia: A case report.
    Kikuchi K; Yasui-Furukori N; Yokoyama S; Hasegawa C; Kokubun A; Katsukura S; Shimizu T; Shimoda K
    Neuropsychopharmacol Rep; 2020 Dec; 40(4):388-391. PubMed ID: 32951324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood dyscrasias in clozapine-treated patients in Italy.
    Lambertenghi Deliliers G
    Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does eosinophilia predict clozapine induced neutropenia?
    Hummer M; Sperner-Unterweger B; Kemmler G; Falk M; Kurz M; Oberbauer H; Fleischhacker WW
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):201-4. PubMed ID: 8935817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine-induced transient white blood count disorders.
    Hummer M; Kurz M; Barnas C; Saria A; Fleischhacker WW
    J Clin Psychiatry; 1994 Oct; 55(10):429-32. PubMed ID: 7961519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Clozapine on Hematological Indices: A 1-Year Follow-Up Study.
    Lee J; Takeuchi H; Fervaha G; Powell V; Bhaloo A; Bies R; Remington G
    J Clin Psychopharmacol; 2015 Oct; 35(5):510-6. PubMed ID: 26267420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of eosinophilia for neutropenia during clozapine treatment.
    Ames D; Wirshing WC; Baker RW; Umbricht DS; Sun AB; Carter J; Schooler NR; Kane JM; Marder SR
    J Clin Psychiatry; 1996 Dec; 57(12):579-81. PubMed ID: 9010121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High risk of eosinophilia in women treated with clozapine.
    Banov MD; Tohen M; Friedberg J
    J Clin Psychiatry; 1993 Dec; 54(12):466-9. PubMed ID: 8276737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
    Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
    Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutropenia induced by second generation antipsychotics: a prospective investigation.
    Rettenbacher MA; Hofer A; Kemmler G; Fleischhacker WW
    Pharmacopsychiatry; 2010 Mar; 43(2):41-4. PubMed ID: 20175050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we prevent blood dyscrasia (leucopenia, thrombocytopenia) and epileptic seizures induced by clozapine.
    Herceg M; Muzinić L; Jukić V
    Psychiatr Danub; 2010 Mar; 22(1):85-9. PubMed ID: 20305597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematological adverse events in clozapine-treated children and adolescents.
    Gerbino-Rosen G; Roofeh D; Tompkins DA; Feryo D; Nusser L; Kranzler H; Napolitano B; Frederickson A; Henderson I; Rhinewine J; Kumra S
    J Am Acad Child Adolesc Psychiatry; 2005 Oct; 44(10):1024-31. PubMed ID: 16175107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful challenge with clozapine in a history of eosinophilia.
    Schuepbach D; Merlo MC; Kaeser L; Brenner HD
    Int Clin Psychopharmacol; 1998 Jan; 13(1):33-7. PubMed ID: 9988365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopharmacologic treatment of psychosis in children and adolescents: efficacy and management.
    Kranzler HN; Cohen SD
    Child Adolesc Psychiatr Clin N Am; 2013 Oct; 22(4):727-44. PubMed ID: 24012083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.
    Atkin K; Kendall F; Gould D; Freeman H; Liberman J; O'Sullivan D
    Br J Psychiatry; 1996 Oct; 169(4):483-8. PubMed ID: 8894200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 infection causes a reduction in neutrophil counts in patients taking clozapine.
    Gee S; Taylor D
    J Psychiatry Neurosci; 2021 Mar; 46(2):E232-E237. PubMed ID: 33703870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Determinants of Clozapine-Induced Metabolic Side Effects.
    Vasudev K; Choi YH; Norman R; Kim RB; Schwarz UI
    Can J Psychiatry; 2017 Feb; 62(2):138-149. PubMed ID: 27681143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reason for clozapine cessation.
    Pai NB; Vella SC
    Acta Psychiatr Scand; 2012 Jan; 125(1):39-44. PubMed ID: 22017729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.